Letter to the Editor regarding the article "SGLT2 inhibitors and cardiovascular and renal outcomes: a meta‑analysis and trial sequential analysis"

Heart Fail Rev. 2022 May;27(3):981-982. doi: 10.1007/s10741-021-10111-y. Epub 2021 May 4.

¹ Department of General Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China. 13798214835@sina.cn.
² Department of Endocrinology, First Affiliated Hospital of Yangtze University, Jingzhou, 434000, China.
³ Class 3, Clinical medicine, Grade 2019, The Second Clinical Medical College, Southern Medical University, Guangzhou, China.
⁴ Department of General Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.

No abstract available

Publication types